Stefania Bellino

2.8k total citations
45 papers, 1.1k citations indexed

About

Stefania Bellino is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Stefania Bellino has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 16 papers in Epidemiology and 11 papers in Oncology. Recurrent topics in Stefania Bellino's work include HIV Research and Treatment (10 papers), COVID-19 Clinical Research Studies (8 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Stefania Bellino is often cited by papers focused on HIV Research and Treatment (10 papers), COVID-19 Clinical Research Studies (8 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Stefania Bellino collaborates with scholars based in Italy, United States and Sweden. Stefania Bellino's co-authors include Patrizio Pezzotti, Antonino Bella, Barbara Ensoli, Giovanni Rezza, Stefano Boros, Flavia Riccardo, Paolo Monini, Alberto Mateo‐Urdiales, Martina Del Manso and Xanthi Andrianou and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and PEDIATRICS.

In The Last Decade

Stefania Bellino

41 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefania Bellino Italy 18 477 359 169 147 129 45 1.1k
Emmanuele Venanzi Rullo Italy 19 456 1.0× 253 0.7× 181 1.1× 203 1.4× 174 1.3× 62 1.2k
Jorge Salinas United States 19 450 0.9× 237 0.7× 147 0.9× 50 0.3× 40 0.3× 100 1.1k
Jane A. O’Halloran United States 20 950 2.0× 308 0.9× 234 1.4× 38 0.3× 171 1.3× 68 1.4k
Doron Netzer Israel 12 941 2.0× 257 0.7× 128 0.8× 69 0.5× 70 0.5× 37 1.5k
Jake Dunning United Kingdom 17 617 1.3× 696 1.9× 145 0.9× 76 0.5× 197 1.5× 57 1.3k
Maximilian Muenchhoff Germany 19 587 1.2× 232 0.6× 236 1.4× 45 0.3× 200 1.6× 47 1.1k
Theresa M. Rossouw South Africa 19 1.2k 2.5× 337 0.9× 435 2.6× 59 0.4× 278 2.2× 87 2.0k
Tal Brosh‐Nissimov Israel 17 522 1.1× 246 0.7× 34 0.2× 63 0.4× 64 0.5× 58 974
Danielle Moulia United States 16 788 1.7× 355 1.0× 140 0.8× 57 0.4× 51 0.4× 31 1.4k
Alexandra Dopfer‐Jablonka Germany 20 875 1.8× 236 0.7× 34 0.2× 188 1.3× 194 1.5× 98 1.8k

Countries citing papers authored by Stefania Bellino

Since Specialization
Citations

This map shows the geographic impact of Stefania Bellino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Bellino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Bellino more than expected).

Fields of papers citing papers by Stefania Bellino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Bellino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Bellino. The network helps show where Stefania Bellino may publish in the future.

Co-authorship network of co-authors of Stefania Bellino

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Bellino. A scholar is included among the top collaborators of Stefania Bellino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Bellino. Stefania Bellino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bellino, Stefania, et al.. (2025). Drug Repurposing of New Treatments for Neuroendocrine Tumors. Cancers. 17(15). 2488–2488.
3.
Vinceti, Marco, Kenneth J. Rothman, Sergio Teggi, et al.. (2022). Substantial impact of mobility restrictions on reducing COVID-19 incidence in Italy in 2020. Journal of Travel Medicine. 29(6). 11 indexed citations
4.
Fabiani, Massimo, Alberto Mateo‐Urdiales, Xanthi Andrianou, et al.. (2020). Epidemiological characteristics of COVID-19 cases in non-Italian nationals notified to the Italian surveillance system. European Journal of Public Health. 31(1). 37–44. 40 indexed citations
5.
Bellino, Stefania, Ornella Punzo, Maria Cristina Rota, et al.. (2020). COVID-19 Disease Severity Risk Factors for Pediatric Patients in Italy. PEDIATRICS. 146(4). 125 indexed citations
6.
Bellino, Stefania, Alberto Borghetti, Francesca Lombardi, et al.. (2019). Trends of hospitalisations rates in a cohort of HIV-infected persons followed in an Italian hospital from 1998 to 2016. Epidemiology and Infection. 147. e89–e89. 12 indexed citations
7.
8.
Pezzotti, Patrizio, Stefania Bellino, Flavia Riccardo, et al.. (2018). Vaccine preventable invasive bacterial diseases in Italy: A comparison between the national surveillance system and recorded hospitalizations, 2007–2016. Vaccine. 37(1). 41–48. 18 indexed citations
9.
Pezzotti, Patrizio, Stefania Bellino, Francesca Prestinaci, et al.. (2018). The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900–2015. Vaccine. 36(11). 1435–1443. 60 indexed citations
10.
Fedele, Giorgio, Pasqualina Leone, Stefania Bellino, et al.. (2017). Diagnostic performance of commercial serological assays measuring Bordetella pertussis IgG antibodies. Diagnostic Microbiology and Infectious Disease. 90(3). 157–162. 5 indexed citations
11.
Torre, Marina, et al.. (2017). Monitoring Outcome of Joint Arthroplasty in Italy: Implementation of the National Registry. Joints. 5(2). 70–78. 20 indexed citations
12.
Cafaro, Aurelio, Antonella Tripiciano, Cecilia Sgadari, et al.. (2015). Development of a novel AIDS vaccine: the HIV-1 transactivator of transcription protein vaccine. Expert Opinion on Biological Therapy. 15(sup1). 13–29. 14 indexed citations
13.
Borsetti, Alessândra, Flavia Ferrantelli, Maria Teresa Maggiorella, et al.. (2014). Effect of MHC Haplotype on Immune Response upon Experimental SHIVSF162P4cy Infection of Mauritian Cynomolgus Macaques. PLoS ONE. 9(4). e93235–e93235. 9 indexed citations
14.
Barillari, Giovanni, André Iovane, Ilaria Bacigalupo, et al.. (2012). Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity. AIDS. 26(8). 909–919. 30 indexed citations
15.
Borsetti, Alessândra, Maria Teresa Maggiorella, Leonardo Sernicola, et al.. (2012). Influence of MHC class I and II haplotypes on the experimental infection of Mauritian cynomolgus macaques with SHIVSF162P4cy. Tissue Antigens. 80(1). 36–45. 7 indexed citations
16.
Borsetti, Alessândra, Silvia Baroncelli, Maria Teresa Maggiorella, et al.. (2009). Containment of Infection in Tat Vaccinated Monkeys After Rechallenge with a Higher Dose of SHIV89.6P cy243. Viral Immunology. 22(2). 117–124. 11 indexed citations
17.
Fanales‐Belasio, Emanuele, Sonia Moretti, Valeria Fiorelli, et al.. (2009). HIV-1 Tat Addresses Dendritic Cells to Induce a Predominant Th1-Type Adaptive Immune Response That Appears Prevalent in the Asymptomatic Stage of Infection. The Journal of Immunology. 182(5). 2888–2897. 41 indexed citations
18.
Monini, Paolo, Cecilia Sgadari, Stefania Bellino, et al.. (2009). Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir. AIDS. 23(4). 534–538. 26 indexed citations
19.
Caputo, Antonella, Riccardo Gavioli, Stefania Bellino, et al.. (2009). HIV-1 Tat-Based Vaccines: An Overview and Perspectives in the Field of HIV/AIDS Vaccine Development. International Reviews of Immunology. 28(5). 285–334. 26 indexed citations
20.
Luzzati, Roberto, Guido Amalfitano, Luca Lazzarini, et al.. (2000). Nosocomial Candidemia in Non-Neutropenic Patients at an Italian Tertiary Care Hospital. European Journal of Clinical Microbiology & Infectious Diseases. 19(8). 602–607. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emmanuele Venanzi Rullo Breakdown of academic impact, for papers by Jorge Salinas Breakdown of academic impact, for papers by Jane A. O’Halloran Breakdown of academic impact, for papers by Doron Netzer Breakdown of academic impact, for papers by Jake Dunning Breakdown of academic impact, for papers by Maximilian Muenchhoff Breakdown of academic impact, for papers by Theresa M. Rossouw Breakdown of academic impact, for papers by Tal Brosh‐Nissimov Breakdown of academic impact, for papers by Danielle Moulia Breakdown of academic impact, for papers by Alexandra Dopfer‐Jablonka
Rankless by CCL
2026